DESCRIPTION • CLINICAL PHARMACOLOGY • INDICATIONS AND USAGE • Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy .
• Prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy .
• Prevention of nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation , single high - dose fraction to the abdomen , or daily fractions to the abdomen .
• Prevention of postoperative nausea and / or vomiting .
As with other antiemetics , routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and / or vomiting will occur postoperatively .
In patients where nausea and / or vomiting must be avoided postoperatively , ondansetron tablets , USP are recommended even where the incidence of postoperative nausea and / or vomiting is low .
CONTRAINDICATIONS • WARNINGS • ADVERSE REACTIONS • DRUG ABUSE AND DEPENDENCE • OVERDOSAGE • DOSAGE AND ADMINISTRATION • PACKAGE LABEL - PRINCIPAL DISPLAY PANEL [ MULTIMEDIA ] [ MULTIMEDIA ] [ MULTIMEDIA ] [ MULTIMEDIA ]
